Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Anemia, Aplastic × ibrutinib × 30 days × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 13 Lymphoma, Non-Hodgkin 6 Lymphoma, Mantle-Cell 5 Waldenstrom Macroglobulinemia 4 Lymphoma, Large B-Cell, Diffuse 4 Lymphoma, Follicular 3 Recurrence 2 Neoplasms 2 Lymphoma 2 Leukemia, Hairy Cell 2 Hematologic Diseases 2 Burkitt Lymphoma 2 Multiple Myeloma 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, B-Cell 1 Leukemia, Lymphoid 1 Leukemia, B-Cell 1 Leukemia 1 Bronchiolitis Obliterans Syndrome 1 Bone Marrow Diseases 1

Interventions

11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡